Skip to content

Seacoast Banking Corporation of Florida SBCF ACL, period increase (decrease)

ACL, period increase (decrease) at other companies

Customers Bancorp logo
Customers BancorpCUBI

Other financials

Income statement

See full
Revenue$163.9M+16.5%
Net income$31.9M+1.4%
EPS (diluted)$0.29-21.6%

Balance sheet

See full
Cash & equivalents$808.4M+61.5%
Total debt$112.8M+5.3%
Total equity$2.7B+21.9%
Total assets$21.1B+34.4%

Cash flow

See full
Operating cash flow$71.8M+132%

Valuation

See full
Market cap$3.08B+34.7%
Enterprise value$2.39B+25.5%
P/E21.2×+3.1×
P/S4.6×+0.2×

Profitability

See full
Net margin21.5%-2.3pp

Returns & leverage

See full
Return on equity5.9%+0.1pp
Debt / equity0.0×

Where this comes from

Reported directly by Seacoast Banking Corporation of Florida in its filing.

Tagged under the XBRL concept us-gaap:FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease.

The official record: Seacoast Banking Corporation of Florida’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Seacoast Banking Corporation of Florida's acl, period increase (decrease).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Seacoast Banking Corporation of Florida's ACL, period increase (decrease)?
Seacoast Banking Corporation of Florida (SBCF) reported ACL, period increase (decrease) of -$2.6M in Q1 2026.
How has Seacoast Banking Corporation of Florida's ACL, period increase (decrease) changed year-over-year?
Seacoast Banking Corporation of Florida's ACL, period increase (decrease) decreased by 218.2% year-over-year, from $2.2M to -$2.6M.